The importance of APC gene mutations in the initiation step of both familial and sporadic colorectal carcinogenesis is well known. Somatic mutations of this gene have also been implicated in pancreatic, gastric and oesophageal cancers. In contrast, only a few APC mutations have been reported in primary human breast cancers. The vast majority of reported APC mutations are protein-truncating, and a novel yeast-based screening method for detection of truncating mutations is presented here. …
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.